PT Kalbe Farma Tbk (PTKFF)
0.0926
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
PT Kalbe Farma 1 Year Total Returns (Daily): -35.27% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -35.27% |
May 02, 2024 | -37.09% |
May 01, 2024 | -37.09% |
April 30, 2024 | -31.80% |
April 29, 2024 | -31.80% |
April 26, 2024 | -31.80% |
April 25, 2024 | -31.80% |
April 24, 2024 | -31.80% |
April 23, 2024 | -31.80% |
April 22, 2024 | -31.80% |
April 19, 2024 | -31.80% |
April 18, 2024 | -31.80% |
April 17, 2024 | -31.80% |
April 16, 2024 | -35.31% |
April 15, 2024 | -35.31% |
April 12, 2024 | -35.45% |
April 11, 2024 | -35.45% |
April 10, 2024 | -35.45% |
April 09, 2024 | -35.45% |
April 08, 2024 | -35.45% |
April 05, 2024 | -35.45% |
April 04, 2024 | -35.45% |
April 03, 2024 | -35.45% |
April 02, 2024 | -35.45% |
April 01, 2024 | -35.45% |
Date | Value |
---|---|
March 28, 2024 | -35.45% |
March 27, 2024 | -35.45% |
March 26, 2024 | -35.45% |
March 25, 2024 | -35.45% |
March 22, 2024 | -35.45% |
March 21, 2024 | -35.45% |
March 20, 2024 | -35.45% |
March 19, 2024 | -35.45% |
March 18, 2024 | -35.45% |
March 15, 2024 | -34.24% |
March 14, 2024 | -34.24% |
March 13, 2024 | -33.70% |
March 12, 2024 | -33.70% |
March 11, 2024 | -33.70% |
March 08, 2024 | -26.99% |
March 07, 2024 | -26.99% |
March 06, 2024 | -26.99% |
March 05, 2024 | -26.99% |
March 04, 2024 | -26.99% |
March 01, 2024 | -26.99% |
February 29, 2024 | -32.45% |
February 28, 2024 | -32.45% |
February 27, 2024 | -32.45% |
February 26, 2024 | -32.45% |
February 23, 2024 | -32.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.54%
Minimum
Mar 26 2020
747.6%
Maximum
Mar 26 2021
9.01%
Average
7.62%
Median
Oct 29 2021
1 Year Total Returns (Daily) Benchmarks
Taihe Group Inc | 1.23% |
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |